Emerging impact of triazoles as anti-tubercular agent
A Sharma, AK Agrahari, S Rajkhowa… - European Journal of …, 2022 - Elsevier
Tuberculosis, a disease of poverty is a communicable infection with a reasonably high
mortality rate worldwide. 10 Million new cases of TB were reported with approx 1.4 million …
mortality rate worldwide. 10 Million new cases of TB were reported with approx 1.4 million …
Extensively drug-resistant tuberculosis
M Jassal, WR Bishai - The Lancet infectious diseases, 2009 - thelancet.com
Extensively drug-resistant (XDR) tuberculosis is defined as disease caused by
Mycobacterium tuberculosis with resistance to at least isoniazid and rifampicin, any …
Mycobacterium tuberculosis with resistance to at least isoniazid and rifampicin, any …
“Big Three” infectious diseases: tuberculosis, malaria and HIV/AIDS
P Makam, R Matsa - Current Topics in Medicinal Chemistry, 2021 - ingentaconnect.com
Infectious diseases have been evolving and re-evolving over the ages and causing
immense misery to humans. Among them, some have been prevented and eradicated, but …
immense misery to humans. Among them, some have been prevented and eradicated, but …
Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs
Tuberculosis is one of the deadliest infectious diseases existing in the world since ancient
times and still possesses serious threat across the globe. Each year the number of cases …
times and still possesses serious threat across the globe. Each year the number of cases …
Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies
TB continues to be a leading health threat despite the availability of powerful anti-TB drugs.
We report herein the design and synthesis of various hybrid molecules comprising pyrazine …
We report herein the design and synthesis of various hybrid molecules comprising pyrazine …
Current perspectives in drug discovery against tuberculosis from natural products
Currently, one third of the world's population is latently infected with Mycobacterium
tuberculosis (MTB), while 8.9–9.9 million new and relapse cases of tuberculosis (TB) are …
tuberculosis (MTB), while 8.9–9.9 million new and relapse cases of tuberculosis (TB) are …
FROM WHENCE THEY CAME—ANTIBIOTIC-RESISTANT ESCHERICHIA COLI IN AFRICAN WILDLIFE
SE Jobbins, KA Alexander - Journal of Wildlife Diseases, 2015 - meridian.allenpress.com
The emergence of antimicrobial resistance is arguably the most important threat to human
and animal health. The impacts of antimicrobial use can reach far from the site of …
and animal health. The impacts of antimicrobial use can reach far from the site of …
Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps
H Ghajavand, M Kargarpour Kamakoli… - … Resistance & Infection …, 2019 - Springer
Background In order to shorten the course of treatment and its effectiveness, it is essential to
gain an in-depth insight into the drug resistance mechanisms of Mycobacterium tuberculosis …
gain an in-depth insight into the drug resistance mechanisms of Mycobacterium tuberculosis …
Unexpected Abundance of Coenzyme F420-Dependent Enzymes in Mycobacterium tuberculosis and Other Actinobacteria
JD Selengut, DH Haft - Journal of bacteriology, 2010 - Am Soc Microbiol
Regimens targeting Mycobacterium tuberculosis, the causative agent of tuberculosis (TB),
require long courses of treatment and a combination of three or more drugs. An increase in …
require long courses of treatment and a combination of three or more drugs. An increase in …
DNA binding, antitubercular, antibacterial and anticancer studies of newly designed piano-stool ruthenium (II) complexes
The chemotherapeutic potential of ruthenium (II) complexes has recently attracted
researchers' interest as antibacterial and anticancer agents. In this study, two novel half …
researchers' interest as antibacterial and anticancer agents. In this study, two novel half …